cor2ed
engage checkpoint medical linkedin twitter
bg

Setting up for treatment success: Podcast on management of patients receiving VEGFR-TKI treatment for select solid tumours

Setting up for treatment success: Podcast on management of patients receiving VEGFR-TKI treatment for select solid tumours

Managing patients both pre- and during VEGFR-TKI treatment is an important consideration. Members of GI NURSES CONNECT and GU NURSES CONNECT give their views as to how nurses can play a key role in setting patients up for treatment success.

Managing patients both pre- and during VEGFR-TKI treatment is an important consideration. Members of GI NURSES CONNECT and GU NURSES CONNECT give their views as to how nurses can play a key role in setting patients up for treatment success.

Veerle Lamotte, Paola Belardi

Listen to the podcast
Portrait of Veerle Lamotte
Veerle Lamotte

Uro-oncological counsellor

Antwerp University Hospital

Belgium

Portrait of Paola Belardi
Paola Belardi

Nurse Chief

San Donato Hospital

Italy

preview next

time Podcast | open 15 min | Sep 2021

Subscribe to our podcast series on:

This programme was made for you:   your opinion matters

Share your feedback in just 4 clicks and help us to continue to create the content you need.

I agree that this educational programme:

In this educational podcast, Veerle Lamotte and Paola Belardi share their successful experience of managing patients treated with VEGFR-TKIs for select solid tumours.

The short 15-minute discussion captures and provides you with their useful insight on:

1. The safety profile of VEGFR-TKIs alone or in combination with PD-1 inhibitors in hepatocellular cancer (HCC), differentiated thyroid cancer (DTC) & advanced renal cell carcinoma (RCC) and how to recognise side effects & understand appropriate management

2. How to best manage patients both prior to & during treatment to ensure optimal treatment success, including prehabilitation of patients prior to treatment & management of side effects on treatment

Veerle and Paola have many years nursing experience and present views not only from the perspective of the nurse, but also with relevance across geographies.

This is the first collaboration between GI NURSES CONNECT and GU NURSES CONNECT on an educational programme offering a valuable resource that is not limited to one tumour type.

This GI NURSES CONNECT and GU NURSES CONNECT podcast is also available on
Castos, Spotify, Apple Podcasts, and Google Podcasts.

GU NURSES CONNECT is an initiative of COR2ED, supported by an Independent Educational Grant from AstraZeneca, Bayer and Eisai Europe Limited.

Other programmes of interest